• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同年龄组韩国糖尿病患者的基线低密度脂蛋白胆固醇水平与心血管疾病风险:一项队列研究。

Risk of Cardiovascular Disease according to Baseline Low-Density Lipoprotein Cholesterol Level in Different Age Groups in Korean Diabetes Population: A Cohort Study.

机构信息

Department of Medicine, MetroWest Medical Center, Framingham, MA, USA.

Department of Statistics and Actuarial Science, Soongsil University, Seoul, Korea.

出版信息

Diabetes Metab J. 2024 Mar;48(2):265-278. doi: 10.4093/dmj.2022.0443. Epub 2024 Feb 26.

DOI:10.4093/dmj.2022.0443
PMID:38403889
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10995493/
Abstract

BACKGRUOUND

The association between low-density lipoprotein (LDL-C) levels and cardiovascular disease (CVD) risk in different age groups within the diabetes mellitus (DM) population remains unclear. The cohort study was conducted to investigate this relationship.

METHODS

We assessed the 2009 to 2012 Korean National Health Screening and National Health Insurance Service records, with follow-up to the primary outcome (myocardial infarction [MI] or stroke) or December 2018. After excluding the participants with a history of MI or stroke, 2,227,394 participants with DM were included and categorized according to baseline LDL-C levels and age. Cox proportional hazards modeling was conducted. The CVD risk of age <40 years and LDL-C <70 mg/dL was set as the reference. In each age group, LDL-C <70 mg/dL was used as a reference for the subgroup analysis.

RESULTS

The cut-off LDL-C value for increased MI risk in each age group varied (<40 years old, LDL-C ≥160 mg/dL: hazard ratios [HR], 2.03; 95% confidence interval [CI], 1.644 to 2.506) (40-49-year-old, LDL-C <115 mg/dL: HR, 1.245; 95% CI, 1.04 to 1.489) (50-59-year-old, LDL-C <115 mg/dL: HR, 1.21; 95% CI, 1.014 to 1.445) (60-69-year-old, LDL-C <145 mg/dL: HR, 1.229; 95% CI, 1.022 to 1.479) (≥70 years old group, LDL-C <100 mg/dL: HR, 1.238; 95% CI, 1.018 to 1.504). The cut-off LDL-C values for increased stroke risk varied in each age subgroup (<40 years old, LDL-C ≥160 mg/dL: HR, 1.395; 95% CI, 1.094 to 1.779) (40-49-year-old, LDL-C <145 mg/dL: HR, 1.13; 95% CI, 1.019 to 1.253) (50-59-year-old, LDL-C <160 mg/dL: HR, 1.079; 95% CI, 1.008 to 1.154) (60-69-year-old, LDL-C <130 mg/dL: HR, 1.07; 95% CI, 1.022 to 1.119) (≥70 years old, LDL-C <115 mg/dL: HR, 1.064; 95% CI, 1.019 to 1.112).

CONCLUSION

The effect of LDL-C on the risk of CVD differs depending on the age of the population with DM.

摘要

背景

糖尿病(DM)患者中不同年龄组的低密度脂蛋白胆固醇(LDL-C)水平与心血管疾病(CVD)风险之间的关系尚不清楚。本队列研究旨在探讨这种关系。

方法

我们评估了 2009 年至 2012 年韩国国家健康筛查和国家健康保险服务记录,并随访主要结局(心肌梗死[MI]或中风)或 2018 年 12 月。排除有 MI 或中风病史的参与者后,纳入 2227394 名 DM 患者,并根据基线 LDL-C 水平和年龄进行分类。采用 Cox 比例风险模型进行分析。年龄<40 岁且 LDL-C<70mg/dL 的 CVD 风险设为参照。在每个年龄组中,将 LDL-C<70mg/dL 作为亚组分析的参照。

结果

每个年龄组中 MI 风险增加的 LDL-C 截断值不同(<40 岁,LDL-C≥160mg/dL:危险比[HR],2.03;95%置信区间[CI],1.644 至 2.506)(40-49 岁,LDL-C<115mg/dL:HR,1.245;95%CI,1.04 至 1.489)(50-59 岁,LDL-C<115mg/dL:HR,1.21;95%CI,1.014 至 1.445)(60-69 岁,LDL-C<145mg/dL:HR,1.229;95%CI,1.022 至 1.479)(≥70 岁组,LDL-C<100mg/dL:HR,1.238;95%CI,1.018 至 1.504)。中风风险增加的 LDL-C 截断值在每个年龄亚组中均有所不同(<40 岁,LDL-C≥160mg/dL:HR,1.395;95%CI,1.094 至 1.779)(40-49 岁,LDL-C<145mg/dL:HR,1.13;95%CI,1.019 至 1.253)(50-59 岁,LDL-C<160mg/dL:HR,1.079;95%CI,1.008 至 1.154)(60-69 岁,LDL-C<130mg/dL:HR,1.07;95%CI,1.022 至 1.119)(≥70 岁,LDL-C<115mg/dL:HR,1.064;95%CI,1.019 至 1.112)。

结论

LDL-C 对 DM 患者 CVD 风险的影响因年龄而异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/704c/10995493/8cbb512b3562/dmj-2022-0443f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/704c/10995493/f9d7ff77fe13/dmj-2022-0443f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/704c/10995493/8cbb512b3562/dmj-2022-0443f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/704c/10995493/f9d7ff77fe13/dmj-2022-0443f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/704c/10995493/8cbb512b3562/dmj-2022-0443f2.jpg

相似文献

1
Risk of Cardiovascular Disease according to Baseline Low-Density Lipoprotein Cholesterol Level in Different Age Groups in Korean Diabetes Population: A Cohort Study.不同年龄组韩国糖尿病患者的基线低密度脂蛋白胆固醇水平与心血管疾病风险:一项队列研究。
Diabetes Metab J. 2024 Mar;48(2):265-278. doi: 10.4093/dmj.2022.0443. Epub 2024 Feb 26.
2
Diabetes Duration, Cholesterol Levels, and Risk of Cardiovascular Diseases in Individuals With Type 2 Diabetes.2 型糖尿病患者的糖尿病病程、胆固醇水平与心血管疾病风险。
J Clin Endocrinol Metab. 2024 Nov 18;109(12):e2317-e2323. doi: 10.1210/clinem/dgae092.
3
Association between Low-Density Lipoprotein Cholesterol Level and Cardiovascular Outcomes in Korean Adults: A Nationwide Cohort Study.韩国成年人的低密度脂蛋白胆固醇水平与心血管结局的关系:一项全国性队列研究。
Diabetes Metab J. 2023 Jan;47(1):59-71. doi: 10.4093/dmj.2021.0320. Epub 2023 Jan 26.
4
Cholesterol levels and development of cardiovascular disease in Koreans with type 2 diabetes mellitus and without pre-existing cardiovascular disease.韩国 2 型糖尿病患者且无既往心血管疾病者的胆固醇水平与心血管疾病的发生发展。
Cardiovasc Diabetol. 2019 Oct 22;18(1):139. doi: 10.1186/s12933-019-0943-9.
5
Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease.在 10 年发生动脉粥样硬化性心血管疾病风险低的个体中,低密度脂蛋白胆固醇与心血管死亡率的长期关联。
Circulation. 2018 Nov 20;138(21):2315-2325. doi: 10.1161/CIRCULATIONAHA.118.034273.
6
Cardiovascular Outcomes according to Comorbidities and Low-Density Lipoprotein Cholesterol in Korean People with Type 2 Diabetes Mellitus.韩国 2 型糖尿病患者的合并症和低密度脂蛋白胆固醇与心血管结局的关系。
Diabetes Metab J. 2023 Jan;47(1):45-58. doi: 10.4093/dmj.2021.0344. Epub 2023 Jan 26.
7
Association of Low-Density Lipoprotein Cholesterol Levels with More than 20-Year Risk of Cardiovascular and All-Cause Mortality in the General Population.低密度脂蛋白胆固醇水平与普通人群 20 多年心血管和全因死亡率的关系。
J Am Heart Assoc. 2022 Aug 2;11(15):e023690. doi: 10.1161/JAHA.121.023690. Epub 2022 Jul 29.
8
Contribution of hypertriglyceridemia to ischemic cardiovascular disease in Korean women: A nationwide population-based study.高甘油三酯血症对韩国女性缺血性心血管疾病的影响:一项全国范围内基于人群的研究。
J Clin Lipidol. 2022 Jan-Feb;16(1):83-93. doi: 10.1016/j.jacl.2021.11.008. Epub 2021 Nov 27.
9
Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus.2型糖尿病血液透析患者中低密度脂蛋白胆固醇和炎症与心血管事件及死亡率的关联
Am J Kidney Dis. 2009 Nov;54(5):902-11. doi: 10.1053/j.ajkd.2009.06.029. Epub 2009 Sep 25.
10
Fenofibrate's impact on cardiovascular risk in patients with diabetes: a nationwide propensity-score matched cohort study.非诺贝特对糖尿病患者心血管风险的影响:一项全国倾向评分匹配队列研究。
Cardiovasc Diabetol. 2024 Jul 18;23(1):263. doi: 10.1186/s12933-024-02353-5.

本文引用的文献

1
Factors Associated with Lack of Health Screening among People with Disabilities Using Andersen's Behavioral Model.运用安德森行为模型分析与残疾人缺乏健康筛查相关的因素
Healthcare (Basel). 2023 Feb 23;11(5):656. doi: 10.3390/healthcare11050656.
2
Association between low-density lipoprotein cholesterol and sudden cardiac arrest in people with diabetes mellitus.低密度脂蛋白胆固醇与糖尿病患者心搏骤停的关系。
Cardiovasc Diabetol. 2023 Feb 20;22(1):36. doi: 10.1186/s12933-023-01769-9.
3
Current Status of the National Health Screening Programs in South Korea.
韩国国家健康筛查项目的现状
Korean J Fam Med. 2022 May;43(3):168-173. doi: 10.4082/kjfm.22.0052. Epub 2022 May 20.
4
Ten-year atherosclerosis cardiovascular disease (ASCVD) risk score and its components among an Iranian population: a cohort-based cross-sectional study.伊朗人群的十年动脉粥样硬化性心血管疾病(ASCVD)风险评分及其组成部分:基于队列的横断面研究。
BMC Cardiovasc Disord. 2022 Apr 9;22(1):162. doi: 10.1186/s12872-022-02601-0.
5
Erratum. 10. Cardiovascular disease and risk management: Standards of Medical Care in Diabetes-2022. Diabetes Care 2022;45(Suppl. 1):S144-S174.勘误。10. 心血管疾病与风险管理:《2022年糖尿病医疗护理标准》。《糖尿病护理》2022年;45(增刊1):S144 - S174。
Diabetes Care. 2022 May 1;45(5):1296. doi: 10.2337/dc22-er05.
6
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022.2. 糖尿病的分类和诊断:2022 年糖尿病医疗护理标准。
Diabetes Care. 2022 Jan 1;45(Suppl 1):S17-S38. doi: 10.2337/dc22-S002.
7
Dyslipidemia, Diabetes and Atherosclerosis: Role of Inflammation and ROS-Redox-Sensitive Factors.血脂异常、糖尿病与动脉粥样硬化:炎症及活性氧-氧化还原敏感因子的作用
Biomedicines. 2021 Nov 3;9(11):1602. doi: 10.3390/biomedicines9111602.
8
2021 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association.2021 年韩国糖尿病协会糖尿病临床实践指南。
Diabetes Metab J. 2021 Jul;45(4):461-481. doi: 10.4093/dmj.2021.0156. Epub 2021 Jul 30.
9
Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study.全球心血管疾病负担及危险因素, 1990-2019:来自 GBD 2019 研究的更新。
J Am Coll Cardiol. 2020 Dec 22;76(25):2982-3021. doi: 10.1016/j.jacc.2020.11.010.
10
World Health Organization 2020 guidelines on physical activity and sedentary behaviour.世界卫生组织 2020 年关于身体活动和 sedentary behaviour 的指南。
Br J Sports Med. 2020 Dec;54(24):1451-1462. doi: 10.1136/bjsports-2020-102955.